Short description
Nanocan Therapeutics provides medicines and other products intended to patients with certain cancers, respiratory tract infections.
Description
Nanocan Therapeutics provides medicines and other products intended to patients with certain cancers, respiratory tract infections. The company leverages nanotechnology to create solutions for hard-to-cure indications where current interventions are insufficient. Through the application of nanotechnology to medicine, Nanocan aims to help improve the quality of life of our patients, increase access to medicine and other treatments, and to reduce global health disparities.
Last funding
Noaccessforu
Sign in for full access
Total funding
$$2020202
Sign in for full access
Location
Princeton, New Jersey, United States, North America
Founded on
January 1, 2020
Non-profit?
No
Acquired?
No
Employees count
1-10
Revenue range
$1230 - 4560
Sign in for full access
Founders
Eric Broyles, Jacques P. Walker